Loomis, Sayles & Company’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-30
| Closed | -$17K | – | 827 |
|
|
2023
Q4 | $17K | Sell |
30
-8
| -21% | -$4.53K | ﹤0.01% | 703 |
|
|
2023
Q3 | $17K | Buy |
+38
| New | +$17K | ﹤0.01% | 707 |
|
|
2023
Q1 | – | Sell |
-36
| Closed | -$15K | – | 1002 |
|
|
2022
Q4 | $15K | Sell |
36
-5
| -12% | -$2.08K | ﹤0.01% | 755 |
|
|
2022
Q3 | $13K | Buy |
41
+5
| +14% | +$1.59K | ﹤0.01% | 651 |
|
|
2022
Q2 | $13K | Buy |
36
+31
| +620% | +$11.2K | ﹤0.01% | 629 |
|
|
2022
Q1 | $3K | Buy |
+5
| New | +$3K | ﹤0.01% | 869 |
|
|
2021
Q4 | – | Sell |
-16
| Closed | -$10K | – | 833 |
|
|
2021
Q3 | $10K | Buy |
+16
| New | +$10K | ﹤0.01% | 807 |
|
|
2021
Q2 | – | Sell |
-26
| Closed | -$13K | – | 870 |
|
|
2021
Q1 | $13K | Hold |
26
| – | – | ﹤0.01% | 722 |
|
|
2020
Q4 | $13K | Buy |
+26
| New | +$13K | ﹤0.01% | 678 |
|